Nerve Support with ALC & ALA — LifeSource VitaminsNerve Support with ALC & ALA — 60 Capsules — Targeted Support for Neuropathy Comfort & Vascular Health*
LifeSource Vitamins Nerve Support pairs Acetyl-L-Carnitine HCl (ALC) and Alpha-Lipoic Acid (ALA)—two extensively studied nutrients for neuropathy—to support nerve comfort, microvascular function, and oxidative balance. Produced in FDA-registered, GMP-certified facilities and
3rd-party tested for identity, purity & potency.*
Research Promise: At LifeSource Vitamins, our commitment is rooted in research and results. Every benefit below is based on human studies verified by the National Institutes of Health (NIH), a world-leading health authority, plus insights from 39 clinically respected organizations and 20 globally renowned health-focused universities.*
Clinically Studied Benefits (with research)
• Neuropathy symptom relief (ALA — mixed evidence) — RCTs and meta-analyses in diabetic peripheral neuropathy report symptom reduction in some trials (not all).
(Mijnhout, 2012 — PMC;
Hsieh, 2023 — PubMed;
Baicus (Cochrane), 2024 — PMC)
• Endothelial/vascular function (ALA) — Placebo-controlled RCTs and pooled analyses show improved flow-mediated dilation and endothelial function.
(Heinisch, 2010 — PubMed;
Tromba, 2019 — PMC;
Jalilpiran meta-analysis, 2021 — PubMed)
• Pain & sensory measures (ALC) — Analyses of randomized, placebo-controlled trials report improvements in pain scores and vibration perception in diabetic neuropathy.
(Sima, 2005 — PubMed;
Li, 2016 — PMC)
• Overall neuropathy outcomes (ALC) — Evidence synthesis notes potential neuroprotective effects in painful peripheral neuropathies; certainty varies by etiology and study quality.
(Di Stefano review, 2019 — PMC)
• Oxidative stress balance (ALA) — Clinical data associate ALA with improved oxidative and microcirculatory indices in diabetes-related neuropathy.
(Hsieh, 2023 — PubMed)
Use note: Trials vary by dose (oral vs IV), duration, and population. ALA has stronger data for short courses and vascular endpoints; ALC data are mixed and depend on dose/form. One prevention trial in chemotherapy-induced neuropathy found ALC was not beneficial and worsened symptoms at 24 weeks—underscoring the importance of clinician guidance.
(Hershman, 2013 — PMC)
*
Additional Studies Showing Promising Benefits*
• Functional improvement with ALA (open-label/RCT) — 16-week oral ALA (600 mg/day) improved neuropathic symptoms vs baseline; withdrawal increased rescue analgesic use.
(GarcÃa-Alcalá, 2015 — PMC)
• Long-term ALA — Four-year study showed no effect on a primary composite but improvements on certain clinical measures.
(Ziegler, 2011 — PubMed)
• Early ALC evidence — RCTs reported symptomatic benefit in diabetic neuropathy; methods and certainty vary across studies.
(De Grandis, 2002 — PubMed;
Quatraro, 1995 — PubMed)
University Studies (Promising — Pre-Clinical / Early Human Data)*
• ALC & nerve regeneration (pre-clinical/early) — University-led work highlights neuroprotective and pro-regenerative actions of ALC in peripheral nerves.
Curran, 2016 — PMC;
Chiechio, 2006 — PMC*
Global Evidence & Authoritative Reviews*
• Cochrane Collaboration — Systematic review of ALA for diabetic peripheral neuropathy (evidence mixed; moderate-certainty suggests little/no effect at 6 months).
Read the Cochrane review (2024)*
• NCCIH (National Center for Complementary and Integrative Health, NIH) — Consumer evidence summary: ALA may help neuropathy pain; evidence mixed; not shown to control blood sugar.
See NCCIH overview*
• StatPearls (NIH/NLM Bookshelf) — Clinical monograph summarizing ALA’s mechanisms, dosing ranges, and evidence in neuropathy.
Open the StatPearls chapter*
We monitor research from leading institutions — including Mayo Clinic, Cleveland Clinic, Harvard, Johns Hopkins, Stanford, Yale, Oxford, Cambridge, MIT, and Oregon State (Linus Pauling Institute) — to keep guidance aligned with credible science.*
Brief Benefit Bullets
• Supports neuropathy comfort in diabetes-related neuropathy (evidence mixed)*
• Promotes healthy endothelial function & oxidative balance*
• ALC + ALA combination for comprehensive nerve support*
• 3rd-party lab tested for identity, potency & purity*
Suggested Use
Take one (1) capsule daily with a meal, or as directed by your healthcare professional. If pregnant, nursing, taking medications (e.g., diabetes, thyroid, anticoagulants), or have a medical condition, consult your physician. Do not exceed recommended dose.*
Product Specifications
• Serving Size — 1 Capsule
• Servings Per Container — 60
• Active Ingredients (per capsule) — Acetyl-L-Carnitine HCl 525 mg; Alpha Lipoic Acid 225 mg
• Other Ingredients — Gelatin (bovine), rice flour, vegetable magnesium stearate, silicon dioxide, vegetable stearic acid
• Free From — Non-GMO; no artificial colors or preservatives*
• Quality — Third-party tested for identity, potency & purity
Perfect For
• Adults seeking research-grounded support for neuropathy comfort*
• Those interested in endothelial/oxidative balance support*
LifeSource Vitamins — Proudly American — Since 1992
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Nerve Support with ALC & ALA — supports neuropathy comfort, endothelial function & oxidative balance; 525 mg ALC HCl + 225 mg ALA per capsule, 60 count. 3rd-party tested. Clinically Studied Ingredients — NIH/PubMed!*
